Suppressing, Stimulating And/or Inhibiting: the Evolving Management of HCC Patient after Liver Transplantation
Critical Reviews in Oncology/Hematology（2024）
Key words
HCC,liver transplantation,immune checkpoint inhibitors,HCC recurrence,acute liver rejection, atezolizumab, bevacizumab, pembrolizumab, TKIs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined